Emtora Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Emtora Biosciences's estimated annual revenue is currently $310k per year.
- Emtora Biosciences's estimated revenue per employee is $77,500
Employee Data
- Emtora Biosciences has 4 Employees.
- Emtora Biosciences grew their employee count by 0% last year.
Emtora Biosciences's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Financial Officer | Reveal Email/Phone |
Emtora Biosciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.7M | 11 | -8% | N/A | N/A |
#2 | $14.9M | 96 | -6% | N/A | N/A |
#3 | $15.2M | 98 | 3% | $1.8M | N/A |
#4 | $1.6M | 10 | 0% | N/A | N/A |
#5 | $3.4M | 22 | 0% | N/A | N/A |
#6 | $2.8M | 18 | 50% | N/A | N/A |
#7 | $7.4M | 48 | -2% | N/A | N/A |
#8 | $0.8M | 5 | 0% | N/A | N/A |
#9 | $1.6M | 10 | 0% | N/A | N/A |
#10 | $16.3M | 105 | 62% | N/A | N/A |
What Is Emtora Biosciences?
Emtora Biosciences is a life science company developing a novel formulation of rapamycin, eRapa™, for use in preventing the onset and recurrence of cancer. A Phase 1b safety and dosing clinical trial is underway in early stage prostate cancer patients. A pilot efficacy study in Familial Adenomatous Polyposis (FAP) is planned for late 2019.
keywords:N/AN/A
Total Funding
4
Number of Employees
$310k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.3M | 4 | 0% | N/A |
#2 | $0.3M | 4 | -20% | N/A |
#3 | $0.3M | 4 | 0% | N/A |
#4 | $0.3M | 4 | 0% | N/A |
#5 | $0.6M | 4 | -20% | N/A |